Conclusions: SGCs emerge as a primary pathophysiological target in the SOD1 transgenic murine model of ALS, clearly reinforcing the pathogenic role of glial cells in motor neuron disease. The gene discussed is SOD1; the disease is amyotrophic lateral sclerosis.